The current screening strategy for kidney disease among people with type 2 diabetes mellitus is missing an estimated 300,000 people in the U.S., according to a study in the June 25 issue of the Journal of the American Medical Association (JAMA) Researchers at UC San Francisco, Loyola University Health System, and colleagues found that 30 percent of adult diabetic patients with kidney disease do not have the two conditions traditionally associated with kidney disease in patients with type 2 diabetes—protein in urine (albuminuria) and eye disease (retinopathy).
June 23, 2003
David A. Kessler, MD, dean of Yale School of Medicine, former commissioner of the U.S. Food and Drug Administration, and one of the nation’s leading public health advocates, today was named dean of the School of Medicine and vice chancellor for medical affairs at the University of California, San Francisco (UCSF).
June 23, 2003
HIGHLIGHTS · Ranks 6th overall among 125 U.S. medical schools. · Ranks 4th in research dollars awarded by the National Institutes of Health. · Ranks 1st for active patents in the University of California system. · Faculty honors: 30 members of the National Academy of Sciences; 44 members of the Institute of Medicine; 33 members of the American Academy of Arts & Sciences; and 16 who are Howard Hughes Medical Investigators.
June 12, 2003
The UCSF School of Medicine will welcome international experts to its Parnassus campus for a global health and education symposium on Friday, June 20, in honor of Haile Debas, MD, who is stepping down after 10 years as the school’s dean. Debas will also be ending his tenure as vice chancellor for medical affairs for UCSF.
June 12, 2003
The 3rd annual UCSF Lesbian Health Research Conference, held in conjunction with San Francisco’s Lesbian, Gay, Bisexual and Transgender Pride Month celebrations, will convene Saturday, June 14, at the San Francisco LGBT Community Center. Kate O’Hanlan, MD, a gynecological oncologist and former Gay and Lesbian Medical Association president will give the keynote presentation to the expected 200 attendees from around the country.
June 11, 2003
The World Health Organization has designated UCSF’s Center for Tobacco Control, Research and Education as a “collaborating center” - part of its international network supporting WHO health initiatives worldwide. The only other WHO collaborating center in the area of tobacco control in North America is the federal Centers for Disease Control and Prevention.
June 10, 2003
Scientists at the University of California, San Francisco have received seven prestigious UC Discovery Grants - state funding paired with private industry support to foster public-private collaboration on important scientific research. Proposals for UC Discovery Grants are competitively peer-reviewed, and grantees pursue research projects on UC campuses. Funding for the seven UCSF research projects totals about $2.6 million. UC Discovery Grants is funding about $1.1 million of the total, with about $1.5 million coming from private industry.
June 09, 2003
UCSF faculty and other academic scientists who are also entrepreneurs or consultants to industry will share their experiences, while an expert on conflict of interest will discuss how to avoid potential pitfalls at UCSF’s third annual BioEntrepreneurship Symposium.
June 05, 2003
Each year the School of Medicine at the University of California, San Francisco presents a total of four Kaiser Teaching Awards-three to faculty on main campus (one each to a member of the clinical department, basic science department, and volunteer clinical faculty), and one to a volunteer clinical faculty member in Fresno. These awards are extremely prestigious and important to faculty. Winners are presented a certificate and a significant monetary reward at the School of Medicine’s commencement in San Francisco.
June 04, 2003
Many types of cancer-like those of the breast and prostate-would not be nearly as deadly if it weren’t for their ability to spread to vital organs. Still, scientists don’t yet fully understand the way in which cancer spreads, or metastasizes, or how to prevent the process. Now, researchers at the San Francisco VA Medical Center (SFVAMC) have used a modified version of a naturally occurring human protein to decrease the spread of human breast cancer implanted in mice.